Evaluating 10 Commercially Available SARS-CoV-2 Rapid Serological Tests by Use of the STARD (Standards for Reporting of Diagnostic Accuracy Studies) Method.
Antibodies, Viral
/ blood
COVID-19
/ blood
COVID-19 Serological Testing
/ methods
Diagnostic Tests, Routine
/ methods
Female
Humans
Immunoassay
Immunoglobulin G
/ blood
Immunoglobulin M
/ blood
Male
Middle Aged
Practice Guidelines as Topic
Retrospective Studies
SARS-CoV-2
/ immunology
Sensitivity and Specificity
COVID-19
IgG
IgM
LFIA
RDT
SARS-CoV-2
analytical performances
antibodies
immunoassays
serology
Journal
Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564
Informations de publication
Date de publication:
21 01 2021
21 01 2021
Historique:
received:
09
09
2020
accepted:
21
11
2020
pubmed:
27
11
2020
medline:
28
1
2021
entrez:
26
11
2020
Statut:
epublish
Résumé
Numerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapid serological tests have been developed, but their accuracy has usually been assessed using very few samples, and rigorous comparisons between these tests are scarce. In this study, we evaluated and compared 10 commercially available SARS-CoV-2 rapid serological tests using the STARD (Standards for Reporting of Diagnostic Accuracy Studies) methodology. Two hundred fifty serum samples from 159 PCR-confirmed SARS-CoV-2 patients (collected 0 to 32 days after the onset of symptoms) were tested with rapid serological tests. Control serum samples (
Identifiants
pubmed: 33239381
pii: JCM.02342-20
doi: 10.1128/JCM.02342-20
pmc: PMC8111137
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Immunoglobulin G
0
Immunoglobulin M
0
Types de publication
Comparative Study
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2021 American Society for Microbiology.
Références
Int J Infect Dis. 2020 May;94:49-52
pubmed: 32251798
Radiology. 2020 Jul;296(1):172-180
pubmed: 32255413
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Ann Intern Med. 2020 Sep 15;173(6):450-460
pubmed: 32496919
Nat Biotechnol. 2020 Oct;38(10):1174-1183
pubmed: 32855547
Wellcome Open Res. 2020 Jun 11;5:139
pubmed: 33748431
J Infect. 2020 Aug;81(2):e39-e45
pubmed: 32504735
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
Emerg Infect Dis. 2020 May;26(5):1052-1054
pubmed: 32091386
CMAJ. 2020 May 11;192(19):E516-E517
pubmed: 32269019
Clin Microbiol Infect. 2020 Aug;26(8):1082-1087
pubmed: 32473953
Am J Respir Crit Care Med. 2020 May 1;201(9):1150-1152
pubmed: 32200654
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Pharmacol Ther. 2002 Jul;95(1):21-45
pubmed: 12163126
Lancet Infect Dis. 2020 Jul;20(7):757-758
pubmed: 32246906
BMJ Open. 2016 Nov 14;6(11):e012799
pubmed: 28137831
Int J Epidemiol. 2021 May 17;50(2):410-419
pubmed: 33615345
J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32245835
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Emerg Microbes Infect. 2020 Dec;9(1):2212-2221
pubmed: 32969769
Emerg Microbes Infect. 2020 Dec;9(1):386-389
pubmed: 32065057